Bedell Frazier Investment Counselling’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-87,061	Closed	-$4.19M	–	71
2015 Q1	$4.19M	Buy	+87,061	New	+$4.19M	1.74%	25